257 related articles for article (PubMed ID: 15929329)
21. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
[TBL] [Abstract][Full Text] [Related]
22. [Quality of life in the course of enzyme replacement therapy for chronic pancreatitis].
Czakó L; Takács T; Lonovics J; Lakner L; Döbrönte Z; Prónai L; Tulassay Z
Orv Hetil; 2002 Jun; 143(25):1521-7. PubMed ID: 12577405
[TBL] [Abstract][Full Text] [Related]
23. Liquid pancreatic enzyme therapy for a patient with short bowel syndrome and chronic pancreatitis in a complicated case of Crohn's disease.
Hardt PD; Helfrich C; Klauke T; Klör HU
Eur J Med Res; 1999 Aug; 4(8):345-6. PubMed ID: 10471547
[TBL] [Abstract][Full Text] [Related]
24. [Effect of pancreatic substitutes on fecal and serum elastase and on pain in patients with chronic pancreatitis].
Aleryani S; Duris I; Payer J; Huorka M; Tesar T; Kratochvíĺová H; Ondrejka P
Vnitr Lek; 2000 May; 46(5):263-7. PubMed ID: 11227180
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
Warwick WJ; Budd JR
Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
[TBL] [Abstract][Full Text] [Related]
26. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic extracts.
Br Med J; 1970 Apr; 2(5702):161-3. PubMed ID: 5440600
[No Abstract] [Full Text] [Related]
28. [Pancreatic enzymes--substitution preparations].
Berndt W
Z Allgemeinmed; 1972 Dec; 48(35):1641-4. PubMed ID: 4649287
[No Abstract] [Full Text] [Related]
29. Chronic pancreatitis.
Holt S
South Med J; 1993 Feb; 86(2):201-7. PubMed ID: 8434293
[TBL] [Abstract][Full Text] [Related]
30. [Clinical therapeutical experiences with mexase].
Nusser E; Donath H
Med Klin; 1968 Jan; 63(4):142-6. PubMed ID: 4233450
[No Abstract] [Full Text] [Related]
31. Exocrine pancreatic substitution: facts and controversies.
Worning H
Scand J Gastroenterol Suppl; 1986; 126():49-54. PubMed ID: 3470919
[TBL] [Abstract][Full Text] [Related]
32. [A comparative cross-over study of pellet pancreatin and tablet pancreatin in chronic pancreatitis].
Herrerías JM; Gómez Parra M; García Montes JM; Petit MA; Valladolid León JM
Rev Esp Enferm Apar Dig; 1989 Dec; 76(6 Pt 2):651-3. PubMed ID: 2633238
[TBL] [Abstract][Full Text] [Related]
33. Management of chronic pancreatitis. Focus on enzyme replacement therapy.
Dobrilla G
Int J Pancreatol; 1989; 5 Suppl():17-29. PubMed ID: 2702247
[TBL] [Abstract][Full Text] [Related]
34. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
Pap A; Varró V
Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
[TBL] [Abstract][Full Text] [Related]
35. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
DeYoung JL
Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic enzymes replacement therapy in chronic pancreatitis: an update.
Trifan A; Balan G; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):646-50. PubMed ID: 12092213
[TBL] [Abstract][Full Text] [Related]
37. Optimal size range for enteric-coated pancreatin preparations.
Lederer PC
Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
[No Abstract] [Full Text] [Related]
38. Choosing and using a pancreatic enzyme supplement.
Drug Ther Bull; 1992 May; 30(10):37-40. PubMed ID: 1591984
[No Abstract] [Full Text] [Related]
39. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis.
O'Keefe SJ; Cariem AK; Levy M
J Clin Gastroenterol; 2001 Apr; 32(4):319-23. PubMed ID: 11276275
[TBL] [Abstract][Full Text] [Related]
40. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Leeuwen DJ; Tytgat GN
Dig Dis Sci; 1998 Jan; 43(1):203-13. PubMed ID: 9508526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
